Evidence map›Paper›PMID 42646679›Full record

ArticleVaccines2026

Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

Prabda Praphasiri, Darunee Ditsungneon, Anusak Kerdsin, Sutthichai Nakphook, Jiraphut Kittiwatanachod, Kanlaya Sornwong, Suriya Naosri, Sarunpattori Khunarsa, Ponthip Wirachwong, Isariya Techatanawat and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Prabda PraphasiriInfluenza and Vaccine Study Center, Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.
Darunee DitsungneonFaculty of Public Health, Kasetsart University Chalermphrakiat Sakon Nakhon Province Campus, Sakon Nakhon 47000, Thailand.
Anusak KerdsinFaculty of Public Health, Kasetsart University Chalermphrakiat Sakon Nakhon Province Campus, Sakon Nakhon 47000, Thailand.ORCID 0000-0003-1055-3656
Sutthichai NakphookInfluenza and Vaccine Study Center, Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.ORCID 0000-0001-5247-0221
Jiraphut KittiwatanachodInfluenza and Vaccine Study Center, Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.ORCID 0009-0000-1239-0518
Kanlaya SornwongInfluenza and Vaccine Study Center, Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.
Suriya NaosriInfluenza and Vaccine Study Center, Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.
Sarunpattori KhunarsaInfluenza and Vaccine Study Center, Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.
Ponthip WirachwongGovernment Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.
Isariya TechatanawatGovernment Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.
Piengthong NarakornGovernment Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.
Somchaiya SurichanGovernment Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.ORCID 0000-0002-1058-5247
Jorge FloresPATH, Seattle, WA 98121, USA.
Laina D MercerPATH, Seattle, WA 98121, USA.ORCID 0000-0002-2517-8900
Christina S PolyakPATH, Seattle, WA 98121, USA.ORCID 0000-0002-9801-2012
Bruce L InnisPATH, Seattle, WA 98121, USA.ORCID 0000-0002-1753-7248
Rama RaghunandanPATH, Seattle, WA 98121, USA.ORCID 0000-0001-8254-0809
Chakrarat PittayawonganonOffice of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand.
Sopon IamsirithawornBureau of Official Inspection, Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand.
Supakit SirilakHealth Systems Research Institute, Nonthaburi 11000, Thailand.
Kriengkrai PrasertInfluenza and Vaccine Study Center, Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.ORCID 0000-0001-8728-5405

Funding

Thailand Science Research and Innovation
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 vaccineinactivated recombinant NDV-HXP-S vaccinephase II clinical trialsecondary immunizationThailand

Identifiers

PMID42646679
PMCPMC13517118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.